Ji-Won Kim
Vorstandsvorsitzender bei AJU IB INVESTMENT CO., LTD.
Vermögen: 272 166 $ am 30.04.2024
Aktive Positionen von Ji-Won Kim
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| AJU IB INVESTMENT CO., LTD. | Direktor/Vorstandsmitglied | 01.01.1999 | - |
| Vorstandsvorsitzender | 01.01.1999 | - | |
Aju IB Investment Co., Ltd. (Private Equity)
 Aju IB Investment Co., Ltd. (Private Equity) Investment ManagersFinance Aju IB Investment Co., Ltd. (Aju IB) is the venture capital subsidiary of AJU Capital Co., Ltd founded in 1974 by Korea Technology Development Corp. The firm is headquartered in Seoul, Korea. | Vorstandsvorsitzender | - | - |
SL VaxiGen, Inc.
 SL VaxiGen, Inc. Pharmaceuticals: MajorHealth Technology SL VaxiGen, Inc. operates as research and development company which engages in developing vaccine therapeutics based on complementary platforms for saving lives. The company was founded on March 3, 2017 and is headquartered in Seongnam, South Korea. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Ji-Won Kim
Ausbildung von Ji-Won Kim
| Yonsei University | Undergraduate Degree |
Statistik
International
| Südkorea | 5 |
Operativ
| Chief Executive Officer | 2 |
| Director/Board Member | 2 |
| Undergraduate Degree | 1 |
Sektoral
| Finance | 3 |
| Health Technology | 2 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| AJU IB INVESTMENT CO., LTD. | Finance |
| Private Unternehmen | 2 |
|---|---|
Aju IB Investment Co., Ltd. (Private Equity)
Aju IB Investment Co., Ltd. (Private Equity) Investment ManagersFinance Aju IB Investment Co., Ltd. (Aju IB) is the venture capital subsidiary of AJU Capital Co., Ltd founded in 1974 by Korea Technology Development Corp. The firm is headquartered in Seoul, Korea. | Finance |
SL VaxiGen, Inc.
SL VaxiGen, Inc. Pharmaceuticals: MajorHealth Technology SL VaxiGen, Inc. operates as research and development company which engages in developing vaccine therapeutics based on complementary platforms for saving lives. The company was founded on March 3, 2017 and is headquartered in Seongnam, South Korea. | Health Technology |
- Börse
- Insiders
- Ji-Won Kim
- Erfahrung
